2026 SAPA-DC Scientific Symposium

As biomedical innovation accelerates, the future of drug discovery is being reshaped by the convergence of New Approach Methodologies (NAMs), artificial intelligence (AI), and human-centric experimental systems. Hosted in the heart of the nation’s regulatory and biomedical ecosystem, this symposium“The Next Chapter of Drug Discovery: Integrating NAMs, AI, and Human-Centric Models in the Regulatory Heartland”brings together scientists, regulators, industry leaders, and technology innovators to explore how these transformative tools can be harmonized to modernize the drug development pipeline.

The symposium will feature three interconnected themes:

• Advancing NAMs and Human-Centric Models：Explore cutting-edge innovations in iPSC technologies, organoids, microphysiological systems, and advanced in vitro platforms that aim to improve human relevance, translational predictability, and efficiency in preclinical research.

• AI-Driven Drug Discovery：Examine how artificial intelligence and machine learning are accelerating target identification, biomarker discovery, compound optimization, and decision-making across the drug development pipeline.

• Regulatory Perspectives and Implementation：Discuss the evolving regulatory landscape surrounding AI and NAMs, including validation frameworks, qualification strategies, data standards, reproducibility, and pathways toward broader adoption and regulatory acceptance.

• Through scientific presentations, panel discussions, and cross-sector dialogue, the event will highlight opportunities and challenges associated with integrating emerging technologies into mainstream biomedical research and regulatory science. By fostering collaboration among scientists, regulators, and innovators, the symposium aims to advance a more predictive, efficient, and human-centric future for therapeutic development.

Event Highlights

· Keynote Presentations

Hear from leaders across academia, industry, and regulatory agencies on the future of AI, NAMs, and translational innovation.

· Scientific Sessions & Case Studies

Explore real-world applications of iPSC models, organoids, organ-on-chip technologies, AI-driven discovery platforms, and integrated translational workflows.

· Regulatory Perspectives & Panel Discussions

Engage with experts on validation, implementation, regulatory acceptance, and global harmonization of emerging methodologies.

· Technology & Innovation Showcase

Discover cutting-edge tools and platforms supporting next-generation drug discovery and human-relevant research.

· Networking Opportunities

Connect with scientists, biotech and pharma professionals, regulators, investors, and technology innovators across the biomedical ecosystem.

Who Should Attend

• Pharmaceutical and biotechnology R&D leaders

• Regulatory scientists and policy makers

• Academic researchers in drug discovery, toxicology, biomedical engineering, and computational biology

• AI and data science professionals in life sciences

• Developers of NAMs, including organ-on-chip and advanced in vitro systems

• Clinical and translational researchers

• CROs and technology providers supporting drug development

• Investors and strategic partners interested in next-generation biomedical innovation.

This symposium is designed for stakeholders seeking to stay at the forefront of scientific, technological, and regulatory transformation in drug discovery.

Don't miss this opportunity to stay ahead of the curve in the pharmaceutical and biotech industries. Register today and secure your spot at the 2026 SAPA-DC Scientific Symposium. We look forward to seeing you there!

The workshop will be held on June 13, 2026, at the Green Court Innovation Center (12358 Parklawn Dr, Rockville, MD 20852).

我们诚挚地邀请您参加2026年SAPA-DC科学论坛，SAPA是一个很好的平台，让来自学术界、行业和监管机构的杰出演讲者和专家分享学术研究、制药和生物技术行业以及监管方面的问题和趋势。